Emzahh Gets FDA Approval for Pregnancy Prevention
Emzahh is an AB-rated generic equivalent of Ortho Micronor.
Diagnosis & Disease Information
FDA Allows Certified Retail Pharmacies to Dispense Mifepristone
Mifepristone is a progestin antagonist indicated, in a regimen with misoprostol, for the medical termination of intrauterine pregnancy through 70 days gestation.
Liletta Approved for Pregnancy Prevention for Up to 8 Years
The approval was based on additional efficacy data from the ACCESS IUS trial.
Case Study: 2-Rod Subdermal Contraceptive Implant in a Recent Immigrant
Case involving a 2-rod subdermal contraceptive implant mistaken for a 1-rod device demonstrates the importance of delivering culturally competent care.
Mirena Approved for Pregnancy Prevention for Up to 8 Years
By the end of the 8th year, Mirena should be removed and replaced at the time of removal with a new system if continued use is desired.
FDA Approves Haloette Vaginal Hormonal Contraceptive Ring
Haloette is an estrogen/progestin combination hormonal contraceptive.
Rx-to-OTC Switch Application Submitted for Oral Contraceptive Opill
If approved, Opill would be the first OTC birth control pill available without a prescription.
Post Hoc Analysis Shows Phexxi Prevented 99% of Pregnancies Per Act of Intercourse
Phexxi is a nonhormonal, on-demand contraceptive designed to regulate vaginal pH in the range of 3.5 to 4.5, maintaining an acidic environment that is inhospitable to sperm.
FDA Extends Shelf Life of On-Demand Contraceptive Phexxi
Phexxi is indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.
At-Home Test Helps With Birth Control Selection by Identifying Risk for Side Effects
Through hormone measurements and genetic analysis, the test can identify whether an individual is at increased risk for certain birth control side effects.
- Loading...
Loading...
Next post in News
Loading... 
Loading...